Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Farmers Insurance
AstraZeneca
Healthtrust
Novartis
Federal Trade Commission
Julphar
Fuji
Colorcon
Express Scripts

Generated: October 22, 2017

DrugPatentWatch Database Preview

TRAVATAN Z Drug Profile

« Back to Dashboard

What is the patent landscape for Travatan Z, and when can generic versions of Travatan Z launch?

Travatan Z is a drug marketed by Novartis Pharms Corp and is included in one NDA. There are three patents protecting this drug and one Paragraph IV challenge.

This drug has forty-three patent family members in twenty-two countries and eleven supplementary protection certificates in eight countries.

The generic ingredient in TRAVATAN Z is travoprost. There are fourteen drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the travoprost profile page.

Summary for Tradename: TRAVATAN Z

US Patents:3
Applicants:1
NDAs:1
Suppliers / Packagers: see list2
Bulk Api Vendors: see list38
Clinical Trials: see list49
Patent Applications: see list1,380
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:TRAVATAN Z at DailyMed

Pharmacology for Tradename: TRAVATAN Z

Ingredient-typeProstaglandins
Drug ClassProstaglandin Analog
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis Pharms Corp
TRAVATAN Z
travoprost
SOLUTION/DROPS;OPHTHALMIC021994-001Sep 21, 2006ATRXYesYes► Subscribe► SubscribeY ► Subscribe
Novartis Pharms Corp
TRAVATAN Z
travoprost
SOLUTION/DROPS;OPHTHALMIC021994-001Sep 21, 2006ATRXYesYes► Subscribe► SubscribeY ► Subscribe
Novartis Pharms Corp
TRAVATAN Z
travoprost
SOLUTION/DROPS;OPHTHALMIC021994-001Sep 21, 2006ATRXYesYes► Subscribe► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: TRAVATAN Z

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Novartis Pharms Corp
TRAVATAN Z
travoprost
SOLUTION/DROPS;OPHTHALMIC021994-001Sep 21, 2006► Subscribe► Subscribe
Novartis Pharms Corp
TRAVATAN Z
travoprost
SOLUTION/DROPS;OPHTHALMIC021994-001Sep 21, 2006► Subscribe► Subscribe
Novartis Pharms Corp
TRAVATAN Z
travoprost
SOLUTION/DROPS;OPHTHALMIC021994-001Sep 21, 2006► Subscribe► Subscribe
Novartis Pharms Corp
TRAVATAN Z
travoprost
SOLUTION/DROPS;OPHTHALMIC021994-001Sep 21, 2006► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV (Patent) Challenges for TRAVATAN Z

Drugname Dosage Strength RLD Submissiondate
travoprost (preserved)Ophthalmic Solution0.00%Travatan Z2/19/2009

International Patent Family for Tradename: TRAVATAN Z

Country Document Number Estimated Expiration
World Intellectual Property Organization (WIPO)2008036847► Subscribe
Taiwan200820962► Subscribe
Japan5394927► Subscribe
Canada2663817► Subscribe
Japan4785970► Subscribe
Mexico2009003042► Subscribe
China101516332► Subscribe
Russian Federation2009114849► Subscribe
South Korea20090058567► Subscribe
Austria531358► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Tradename: TRAVATAN Z

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
00540Netherlands► SubscribePRODUCT NAME: TRAVOPROST; REGISTRATION NO/DATE: EU/1/01/199/001-002 20011127
1920764/01Switzerland► SubscribePRODUCT NAME: TRAVOPROST; REGISTRATION NUMBER/DATE: SWISSMEDIC 55910 22.05.2002
12/033Ireland► SubscribePRODUCT NAME: TRAVOPROST (ALSO CALLED FLUPROSTENOL ISOPROPYL ESTER); NAT REGISTRATION NO/DATE: EU/1/01/199/001-002 20011129; FIRST REGISTRATION NO/DATE: EU/1/01/199/001-002 20011129; PAEDIATRIC INVESTIGATION PLAN: P/0298/2013 PROCEEDINGS UNDER SECTION 37 OF THE PATENTS ACT, 1992 RESTORATION ORDER DATED 12TH JANUARY 2016, WAS MADE RESTORING THE PATENT MENTIONED BELOW S85583 PAUL DOYLE A RE-USABLE BAG SYSTEM RESTORATION ORDERS DATED 16TH FEBRUARY 2016, WERE MADE RESTORING THE PATENTS MENTIONED BELOW S86133 MERVYN GREENE MULTI PURPOSE TANK STAND WITH COMPLEX LOCKING MECHANISM 86119 MPC GREEN LIMITED ANEW BIN
2014029Lithuania► SubscribePRODUCT NAME: TRAVOPROSTUM; REGISTRATION NO/DATE: EU/1/01/199/001 - EU/1/01/199/002 20011129
2012017,C1920764Lithuania► SubscribePRODUCT NAME: TRAVOPROSTUM; NAT. REGISTRATION NO/DATE: LT 02/7821/3 20020402; FIRST REGISTRATION: EU/1/01/199/001 - EU/1/01/199/002 20011127
90027-0Sweden► SubscribePRODUCT NAME: TRAVOPROST
2014 00038Denmark► SubscribePRODUCT NAME: TRAVOPROST; REG. NO/DATE: EU/1/01/199/001-002 20011127
C0045France► SubscribePRODUCT NAME: TRAVOPROST; REGISTRATION NO/DATE: EU/1/01/199/001 20011127
00671Netherlands► SubscribePRODUCT NAME: TRAVOPROST; REGISTRATION NO/DATE: EG EU/1/01/199/001-002 20011128
C/GB12/038United Kingdom► SubscribePRODUCT NAME: TRAVOPROST; REGISTERED: UK EU/1/01/199/001-002 20011129
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

McKinsey
UBS
QuintilesIMS
US Army
AstraZeneca
McKesson
Novartis
Fuji
Boehringer Ingelheim
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot